cannabidiol	(CBD)
∆9-tetrahydrocannabinol	(THC)
cannabinoid receptor	(CB)
transient receptor potential	(TRP)
non-small cell lung cancer	(NSCLC)
Small cell lung cancer	(SCLC)
mitogen-activated protein kinase	(MAPK)
lymphokine-activated killer	(LAK)
cyclooxygenase-2	(COX-2)
reactive oxygen species	(ROS)
epithelial-to-mesenchymal transition	(EMT)
epidermal growth factor	(EGF)
epidermal growth factor receptor	(EGFR)
vascular endothelial growth factor	(VEGF)
unfolded protein response	(UPR)
hypoxia-induced factor-1α	(HIF-1α)
doxorubicin	(DOX)
Src/von Hippel–Lindau tumor suppressor protein	(VHL)
extracellular vesicles encapsulated with CBD	(CBD EVs)
androgen receptor	(AR)
p53-up-regulated modulator of apoptosis	(PUMA)
C/EBP homologous protein	(CHOP)
exosome and microvesicle	(EMV)
colorectal cancer	(CRC)
G protein coupled receptor 55	(GPR55)
inositol requiring enzyme-1α	(RE1α)
phosphorylated protein kinase RNA-like ER kinase	(PERK)
TNF-related apoptosis-inducing ligand	(TRAIL)
azoxymethane	(AOM)
aberrant crypt foci	(AFC)
superoxide dismutase	(SOD)
glutathione peroxidase	(GPx)
glutathione reductase	(GR)
mitochondrial permeability transition pore complex	(MPTP)
glutathione	(GSH)
oxidized glutathione	(GSSG)
ascorbic acid	(AA)
catalase	(CAT)
malondialdehyde	(MDA)
nitric oxide synthase 3	(NOS3)
AMP-activated protein kinase	(AMPK)
nitric oxide	(NO)
randomized controlled trials	(RCT)